Correlation between plasma lipid levels in patients with different oral pre-cancerous lesions
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20212817Keywords:
Oral pre-malignant lesions, Lipid levelsAbstract
Background: Oral precancerous lesions could be defined as the lesions present in oral cavity that have a potential to become cancer. Recognition of precancerous lesions has its own significance as it helps in early detection of risk of cancer which in itself is quite useful for formulating appropriate preventive strategies that could assure better survival rates. The aim of the study was to assess the correlation of lipid levels in patients with different oral precancerous lesions.
Methods: A total of 150 patients with oral lesions attending the department of otorhinolaryngology at Era’s Lucknow Medical college and Hospital, Lucknow, were included in the study. A biopsy specimen was taken from each patient along with 5 ml fasting blood sample for serum lipid estimation which was done by dry chemistry Chemino Heinz method.
Results: A total of 150 patients with age ranging from 13-70 years and a male is to female ratio of 1.68 was studied. Burning sensation was the most common symptom and OSMF being the most common diagnosis. All the components of lipid profile except HDL of patients with different histopathological diagnosis were found to be comparable. No association of derangement in any of the components of lipid levels and histopathological diagnosis was observed.
Conclusions: The findings of present study showed that lipid levels in patients with precancerous oral lesions are generally of lower order. However, the present study could not assess a significant association between lipid levels and different types of oral premalignant lesions.
Metrics
References
Dowell JD. An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am. 2006;39(2):277-94.
Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005 Jun 4-10;365(9475):1927-33.
Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39(8):770-80.
Souza C, Pawar U, Chaturvedi P. Precancerous Lesions of Oral Cavity. Otorhinolaryngology Clinics. Int J. 2009;1(1):7-17.
Vlkova B, Stanko P, Minarik G, Tothova L, Szemes T, Banasova L, et al. Salivary markers of oxidative stress in patients with oral premalignant lesions. Arch Oral Biol. 2012;57(12):1651-6.
Warnakulasuriya S, Johnson NW, Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575-80.
Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol. 2001;54(3):176-86.
Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4(8):118-26.
Chawda JG, Jain SS, Patel HR, Chaduvula N, Patel K. The relationship between serum lipid levels and the risk of oral cancer. Indian J Med Paediatr Oncol. 2011;32(1):34-7.
Ryan BM, Badger JM. The hallmarks of premalignant conditions: a molecular basis for cancer prevention. Semin Oncol. 2016;43(1):22-35.
Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239-67.
Kamath A, Shashidhar KN, Anantharamaiah H, Rangareddy H, Sathyanarayana VB. Risk factors, lipid profile, and histopathological study of oral cancers in Kolar district: a case-control study. J Cancer Res Ther. 2014;10(1):171-5.
Mehta R, Gurudath S, Dayansoor S, Pai A, Ganapathy KS. Serum lipid profile in patients with oral cancer and oral precancerous conditions. Dent Res J. 2014;11(3):345-50.
Mehrotra R, Pandya S, Chaudhary AK, Singh HP, Jaiswal RK, Singh M, et al. Lipid profile in oral submucous fibrosis. Lipids Health Dis. 2009;8:29.
Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis. 2011;17(1):42-57.
16. Ambekar DM, Chaudhary BJ and Kulkarni VV. A study of prevalence of oral precancerous lesions in relation to tobacco habituation. Int J Med Clin Res. 2014;5(1):282-5.
Narasannavar A, Wantamutte AS. Prevalence of oral precancerous lesions and conditions among tobacco consumers in rural population around Belgaum. A community based cross sectional study. IOSR J Dental Med Sci. 2014;13(4):31-4.
Kanthem RK, Guttikonda VR. Serum lipid profile in oral submucous fibrosis: A clinico pathological study. J Oral Maxillofac Pathol. 2015;19(2):139-44.
Mehta R, Gurudath S, Dayansoor S, Pai A, Ganapathy KS. Serum lipid profile in patients with oral cancer and oral precancerous conditions. Dent Res J. 2014;11(3):345-50.
Subbulakshmi AC, Mohan N, Thiruneervannan R, Naveen S. Comparative Evaluation of Serum Lipid Profile in Patients with Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with that of Control Subjects: A Case Control Study. J Pharm Bioallied Sci. 2017;9(1):191-6.
Pindborg JJ. Is submucous fibrosis a precancerous condition in the oral cavity?. Int Dent J. 1972;22(4):474-80.
Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, et al. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer. 2004;41:25-31.
Goel P, Garg R, Raghavan V. Lipid profile in oral potentially malignant disorders. J Indian Acad Oral Med Radiol. 2014;26:374-8.
Mujoo S, Shashikant MC, Dubey A, Dubey A. Correlation of lipid profile and glycemia in oral precancerous lesion and condition. Int J Therapeutic Applicat. 2016;33:119-28.
Downloads
Published
How to Cite
Issue
Section
